Essential Reads: Guidelines for the Use of Electroconvulsive Therapy During Pregnancy
Electroconvulsive therapy (ECT) is a safe and effective treatment for many psychiatric illnesses occurring during pregnancy.
Essential Reads: SBIRT for Women with Alcohol and Drug Use During Pregnancy
Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective means of identifying and intervening with patients whose patterns of use put them at risk for, or who already have, substance-related health problems.
Essential Reads: Zuranolone for Postpartum Depression
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Essential Reads: A Clinical Guide for the Diagnosis and Treatment of PMDD
In an evidence-based review published in 2012, Laura Wakil, Samantha Meltzer-Brody, and Susan Girdler present a thorough review of premenstrual dysphoric disorder (PMDD), reviewing its diagnosis and treatment options.
Essential Reads: ADHD in Girls and Women
In childhood, ADHD is clearly more common in boys than in girls; however, in adult samples, the sex differences in prevalence are mush smaller. There is also increasing recognition that girls and women may present [...]
Essential Reads: Should Lithium Dose Be Reduced Prior to Delivery?
The dosing of lithium presents certain challenges during pregnancy. During pregnancy, there is a physiologic increase in the glomerular filtration rate (GFR), which is a measure of how quickly the kidney clears renally excreted compounds, [...]
Essential Reads: Evidence-Based Interventions for Depressed Mothers and Their Young Children
In a given year, about 10% of mothers in the United States experience a major depressive episode (MDE). Roughly translated, this means about 1 in 10 children is exposed to maternal depression each year (Ertel [...]
Recruiting New Mothers with Postpartum Depression for the Skylark Study
In 2019, brexanolone was introduced by Sage Therapeutics as Zulresso, a novel treatment for postpartum depression. The oral version of this novel antidepressant – SAGE 217 or zuranolone – is now finishing up its Phase [...]
A Novel Treatment for PMDD: Ulipristal Acetate, a Progesterone Receptor Modulator
While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]
Essential Reads:Â Ovarian Suppression for the Treatment of Severe PMDD
While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]